Circulating full-length cytokeratin 18 for predicting prognosis of hepatitis B virus-related acute-on-chronic liver failure patients with lamivudine treatment.
about
Circulating full-length cytokeratin 18 for predicting prognosis of hepatitis B virus-related acute-on-chronic liver failure patients with lamivudine treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Circulating full-length cytoke ...... nts with lamivudine treatment.
@en
type
label
Circulating full-length cytoke ...... nts with lamivudine treatment.
@en
prefLabel
Circulating full-length cytoke ...... nts with lamivudine treatment.
@en
P2093
P2860
P356
P1433
P1476
Circulating full-length cytoke ...... nts with lamivudine treatment.
@en
P2093
P2860
P304
P356
10.1111/HEPR.12549
P577
2015-07-02T00:00:00Z